Prevalence of metabolic syndrome in Taiwanese adults: A hospital-based study

Annals of Saudi Medicine

Volumn 26, Issue 1, 2006, Pages 46-48

  Lin, Chih Hsueh ^a   Lai, Shih Wei ^a   Liu, Chiu Shon ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ANAMNESIS; ARTICLE; BIOCHEMISTRY; BLOOD CHEMISTRY; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEALTH STATUS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL EXAMINATION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE; STATISTICAL ANALYSIS; TAIWAN; UNIVERSITY HOSPITAL;

EID: 33644524084     PISSN: 13199226     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.2006.46     Document Type: Article

References (12)

1. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MR Prospective analyses of the insulin resistance syndrome (syndrome X). Diabetes 1992; 41:715-22.
2. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Mad 1993; 44:121-31.
3. Maigs JB. Epidemiology of the metabolic syndrome, 2002. Am J Manag Care. 2002, 11 :s283-92;
4. Bloomagarden ZT. American Association of Clinical Endocrinologists (AACE) Consensus Conference on the insulin Resistance Syndrome. Diabetes Care 2003; 26:933-9
5. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin actionin man. Am J Physiol 1985;11 :E286-91
6. Chuang SY, Chen CH, Chou F. Prevalence of metabolic syndrome in a large health check-up population in Taiwan. J Chin Mod Assoc 2004,12:611-20
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-97.
8. Inoue S, P Zimmet. The Asia-Pacific perspective: redefining obesity and its treatment Sydney: Health Communications Australia Pty. 2000:17-20.
9. Chuang SY, Chen CH, Tsai ST, Chou F. Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiol Sin 2002; 18:16-23.
10. Park YW, Zhu S, Palaniappan L, heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Mad 2003;163: 427-36.
11. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Med 2002; 346:393-403.